While these indirect findings are valuable in understanding the broader implications of semaglutide on hormonal regulation, they do not offer conclusive evidence regarding the medications specific impact on the menstrual cycle
Liraglutide, the active ingredient in Victoza, another blockbuster weight loss medication, is still listed under the FDA registry as being in short supply and thats why they can still compound and sell it, he says
Speaking to Your GP About GLP-1 and Hashimoto's Before pursuing GLP-1 therapy for Hashimoto's-related metabolic symptoms, discuss NHS eligibility criteria, evidence limitations, and potential interactions with levothyroxine with your GP or endocrinologist
Overall, 1,443 (57.1 percent) of the 2,529 live-birth pregnancies received at least one GLP-1 RA dispensation after LMP, and 1,499 (829 with continued dispensing) were linked to an infant
BPC 157 is not a substance that is legal or in compliance with the FDA for use in humans (1)
SeekPeptides has been tracking this story closely because it affects every single person in the peptide research community